Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Obesity as a risk factor for Alzheimer's disease: weighing the evidence
Susan Alford, Dhiren Patel, Nikolaos Perakakis, et al.
Obesity Reviews (2017) Vol. 19, Iss. 2, pp. 269-280
Open Access | Times Cited: 193

Showing 1-25 of 193 citing articles:

Comprehensive Review on Alzheimer’s Disease: Causes and Treatment
Zeinab Breijyeh, Rafik Karaman
Molecules (2020) Vol. 25, Iss. 24, pp. 5789-5789
Open Access | Times Cited: 1812
Obesity and cancer risk: Emerging biological mechanisms and perspectives
Konstantinos Avgerinos, Nikolaos Spyrou, Christos S. Mantzoros, et al.
Metabolism (2018) Vol. 92, pp. 121-135
Open Access | Times Cited: 1237
A 2022 update on the epidemiology of obesity and a call to action: as its twin COVID-19 pandemic appears to be receding, the obesity and dysmetabolism pandemic continues to rage on
Chrysoula Boutari, Christos S. Mantzoros
Metabolism (2022) Vol. 133, pp. 155217-155217
Open Access | Times Cited: 636
Exercise benefits on Alzheimer’s disease: State-of-the-science
Pedro L. Valenzuela, Adrián Castillo‐García, Javier S. Morales, et al.
Ageing Research Reviews (2020) Vol. 62, pp. 101108-101108
Closed Access | Times Cited: 241
Pharmacotherapy of obesity: Available medications and drugs under investigation
Eleni Pilitsi, Olivia M. Farr, Stergios A. Pοlyzos, et al.
Metabolism (2018) Vol. 92, pp. 170-192
Open Access | Times Cited: 229
Association Between Midlife Obesity and Its Metabolic Consequences, Cerebrovascular Disease, and Cognitive Decline
Filip Morys, Mahsa Dadar, Alain Dagher
The Journal of Clinical Endocrinology & Metabolism (2021) Vol. 106, Iss. 10, pp. e4260-e4274
Open Access | Times Cited: 106
Butyrate ameliorates quinolinic acid–induced cognitive decline in obesity models
Xing Ge, Mingxuan Zheng, Minmin Hu, et al.
Journal of Clinical Investigation (2023) Vol. 133, Iss. 4
Open Access | Times Cited: 48
Obesity-induced inflammation: connecting the periphery to the brain
Ophélia Le Thuc, Cristina García‐Cáceres
Nature Metabolism (2024) Vol. 6, Iss. 7, pp. 1237-1252
Closed Access | Times Cited: 19
Crosstalk between obesity, diabetes, and alzheimer’s disease: Introducing quercetin as an effective triple herbal medicine
Shiva Ebrahimpour, Mansoureh Zakeri, Abolghasem Esmaeili
Ageing Research Reviews (2020) Vol. 62, pp. 101095-101095
Closed Access | Times Cited: 127
The long and short term effects of motherhood on the brain
Paula Duarte‐Guterman, Benedetta Leuner, Liisa A.M. Galea
Frontiers in Neuroendocrinology (2019) Vol. 53, pp. 100740-100740
Closed Access | Times Cited: 117
Role of the metabolism of branched-chain amino acids in the development of Alzheimer's disease and other metabolic disorders
Baruh Polis, AbrahamO Samson
Neural Regeneration Research (2020) Vol. 15, Iss. 8, pp. 1460-1460
Open Access | Times Cited: 94
The Cognitive Control of Eating and Body Weight: It’s More Than What You “Think”
Terry L. Davidson, Sabrina Jones, Megan Roy, et al.
Frontiers in Psychology (2019) Vol. 10
Open Access | Times Cited: 93
On the central role of mitochondria dysfunction and oxidative stress in Alzheimer’s disease
Tobore Onojighofia Tobore
Neurological Sciences (2019) Vol. 40, Iss. 8, pp. 1527-1540
Closed Access | Times Cited: 93
Olfactory Dysfunction Mediates Adiposity in Cognitive Impairment of Type 2 Diabetes: Insights From Clinical and Functional Neuroimaging Studies
Zhou Zhang, Bing Zhang, Xin Wang, et al.
Diabetes Care (2019) Vol. 42, Iss. 7, pp. 1274-1283
Open Access | Times Cited: 88
Neuroinflammation and White Matter Alterations in Obesity Assessed by Diffusion Basis Spectrum Imaging
Amjad Samara, Tatianna Murphy, Jeremy F. Strain, et al.
Frontiers in Human Neuroscience (2020) Vol. 13
Open Access | Times Cited: 76
Targeting whole body metabolism and mitochondrial bioenergetics in the drug development for Alzheimer's disease
Steven N. Austad, Scott W. Ballinger, Thomas W. Buford, et al.
Acta Pharmaceutica Sinica B (2021) Vol. 12, Iss. 2, pp. 511-531
Open Access | Times Cited: 56
Fecal Microbiota Transplantation Reduces Pathology and Improves Cognition in a Mouse Model of Alzheimer’s Disease
Shalini Elangovan, Thomas J. Borody, R. M. Damian Holsinger
Cells (2022) Vol. 12, Iss. 1, pp. 119-119
Open Access | Times Cited: 42
The link between metabolic syndrome and Alzheimer disease: A mutual relationship and long rigorous investigation
Haydar M. Al‐kuraishy, Majid S. Jabir, Ali K. Albuhadily, et al.
Ageing Research Reviews (2023) Vol. 91, pp. 102084-102084
Closed Access | Times Cited: 32
Probiotic Clostridium butyricum ameliorates cognitive impairment in obesity via the microbiota-gut-brain axis
Mingxuan Zheng, Huaiyu Ye, Xiaoying Yang, et al.
Brain Behavior and Immunity (2023) Vol. 115, pp. 565-587
Closed Access | Times Cited: 30
N-acetylneuraminic acid links immune exhaustion and accelerated memory deficit in diet-induced obese Alzheimer’s disease mouse model
Stefano Suzzi, Tommaso Croese, Adi Ravid, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 24
Ceramides are fuel gauges on the drive to cardiometabolic disease
Joseph L. Wilkerson, Sean M. Tatum, William L. Holland, et al.
Physiological Reviews (2024) Vol. 104, Iss. 3, pp. 1061-1119
Closed Access | Times Cited: 11
Adipose and skeletal muscle thermogenesis: studies from large animals
John‐Paul Fuller‐Jackson, Belinda A. Henry
Journal of Endocrinology (2018) Vol. 237, Iss. 3, pp. R99-R115
Open Access | Times Cited: 79
High fat diet worsens Alzheimer’s disease-related behavioral abnormalities and neuropathology in APP/PS1 mice, but not by synergistically decreasing cerebral blood flow
Oliver Bracko, Lou Vinarcsik, Jean C. Cruz Hernández, et al.
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 69
Liraglutide and a lipidized analog of prolactin-releasing peptide show neuroprotective effects in a mouse model of β-amyloid pathology
Martina Holubová, Lucie Hrubá, Andrea Popelová, et al.
Neuropharmacology (2018) Vol. 144, pp. 377-387
Closed Access | Times Cited: 66
Contributions of a high-fat diet to Alzheimer's disease-related decline: A longitudinal behavioural and structural neuroimaging study in mouse models
Colleen Rollins, Daniel Gallino, Vincent Kong, et al.
NeuroImage Clinical (2018) Vol. 21, pp. 101606-101606
Open Access | Times Cited: 66
Page 1 - Next Page

Scroll to top